Jeff Yass’s CalciMedica CALC Stock Holding History

Jeff Yass’s Portfolio CALC Stock Details CALC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-36,000	Closed	-$103K	–	12237
2023 Q4	$103K	Hold	36,000	–	–	﹤0.01%	11309
2023 Q3	$93.2K	Hold	36,000	–	–	﹤0.01%	10977
2023 Q2	$144K	Buy	+36,000	New	+$157K	﹤0.01%	10615
2023 Q1	–	Sell	-2,579	Closed	-$18.1K	–	12618
2022 Q4	$18.1K	Hold	2,579	–	–	﹤0.01%	11794
2022 Q3	$34K	Hold	2,579	–	–	﹤0.01%	12407
2022 Q2	$39K	Sell	2,579 -2,571	-50%	-$35.1K	﹤0.01%	12104
2022 Q1	$89K	Sell	5,150 -2,393	-32%	-$45.6K	﹤0.01%	11984
2021 Q4	$193K	Sell	7,543 -36	-0.5%	-$1.4K	﹤0.01%	11484
2021 Q3	$352K	Buy	7,579 +1,708	+29%	+$96K	﹤0.01%	10231
2021 Q2	$446K	Buy	+5,871	New	+$385K	﹤0.01%	9856

Other funds holding CALC

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

HCM

Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return

SCM

Squadron Capital Management Westmont, Illinois $322M AUM

Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

LGM

L1 Global Manager Melbourne $142M AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jeff Yass's CALC Position: Q2 2026 in Review

Jeff Yass increased its CalciMedica (CALC) stake by 43% in Q2 2026, buying an estimated $9.39K and bringing the position to 43,968 shares worth $45.3K. The position accounts for ﹤0.01% of the portfolio, ranked #12862.

Jeff Yass first reported a position in CALC in Q2 2021 and has held it in 7 quarters since. The position peaked at $1.46M in Q2 2021. 31 funds tracked by Wall St. Rank hold CALC as of Q2 2026.

Jeff Yass held 43,968 shares of CalciMedica worth $45.3K as of Q2 2026.
Jeff Yass bought 13,252 CalciMedica shares in Q2 2026, an estimated $9.39K.
CalciMedica made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #12862 holding.
Jeff Yass first reported a position in CalciMedica in Q2 2021 and has held it in 7 quarters since.
Jeff Yass's CalciMedica position peaked at $1.46M in Q2 2021.
31 funds tracked by Wall St. Rank held CalciMedica as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.